145 related articles for article (PubMed ID: 36252747)
21. Intensified Total Neoadjuvant Therapy
DE Felice F; Musio D; Iafrate F; Caponnetto S; Picone V; D'Ambrosio G; Magliocca FM; Tozzi F; DE Toma G; Tombolini V; Cortesi E
Anticancer Res; 2022 Feb; 42(2):991-1000. PubMed ID: 35093899
[TBL] [Abstract][Full Text] [Related]
22. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].
Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307
[No Abstract] [Full Text] [Related]
23. Pathological Complete Response Following Different Neoadjuvant Treatment Strategies for Locally Advanced Rectal Cancer: A Systematic Review and Meta-analysis.
Hoendervangers S; Burbach JPM; Lacle MM; Koopman M; van Grevenstein WMU; Intven MPW; Verkooijen HM
Ann Surg Oncol; 2020 Oct; 27(11):4319-4336. PubMed ID: 32524461
[TBL] [Abstract][Full Text] [Related]
24. Feasibility of relatively low neoadjuvant radiation doses for locally advanced rectal cancer: A propensity score-matched analysis.
Ye W; Shi L; Qian L; Sun Y; Sun X
Cancer Rep (Hoboken); 2019 Oct; 2(5):e1188. PubMed ID: 32721108
[TBL] [Abstract][Full Text] [Related]
25. Comment on: Total neoadjuvant therapy versus chemoradiotherapy for locally advanced rectal cancer: Bayesian network meta-analysis.
Zhang W; Huang J
Br J Surg; 2024 Jan; 111(1):. PubMed ID: 37995275
[No Abstract] [Full Text] [Related]
26. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial.
Bahadoer RR; Dijkstra EA; van Etten B; Marijnen CAM; Putter H; Kranenbarg EM; Roodvoets AGH; Nagtegaal ID; Beets-Tan RGH; Blomqvist LK; Fokstuen T; Ten Tije AJ; Capdevila J; Hendriks MP; Edhemovic I; Cervantes A; Nilsson PJ; Glimelius B; van de Velde CJH; Hospers GAP;
Lancet Oncol; 2021 Jan; 22(1):29-42. PubMed ID: 33301740
[TBL] [Abstract][Full Text] [Related]
27. Fluorouracil-based neoadjuvant chemoradiotherapy with or without oxaliplatin for treatment of locally advanced rectal cancer: An updated systematic review and meta-analysis.
Yang YJ; Cao L; Li ZW; Zhao L; Wu HF; Yue D; Yang JL; Zhou ZR; Liu SX
Oncotarget; 2016 Jul; 7(29):45513-45524. PubMed ID: 27322422
[TBL] [Abstract][Full Text] [Related]
28. Optimal interval to surgery after chemoradiotherapy in rectal cancer: A protocol for systematic review and network meta-analysis.
Chen YJ; Zhao ZJ; Wang BW; Jing GZ; Ma HK; Han X; Wang J; Zhao ZJ
Medicine (Baltimore); 2019 Nov; 98(45):e17669. PubMed ID: 31702618
[TBL] [Abstract][Full Text] [Related]
29. Author response: Total neoadjuvant therapy versus chemoradiotherapy for locally advanced rectal cancer: Bayesian network meta-analysis.
Wu Q; He Y; Wang Z
Br J Surg; 2024 Jan; 111(1):. PubMed ID: 37995277
[No Abstract] [Full Text] [Related]
30. Pilot study of intense neoadjuvant chemoradiotherapy for locally advanced rectal cancer: retrospective review of a phase II study.
Xu BH; Chi P; Guo JH; Guan GX; Tang TL; Yang YH; Chen MQ; Song JY; Feng CY
Tumori; 2014; 100(2):149-57. PubMed ID: 24852858
[TBL] [Abstract][Full Text] [Related]
31. Improved Metastasis- and Disease-Free Survival With Preoperative Sequential Short-Course Radiation Therapy and FOLFOX Chemotherapy for Rectal Cancer Compared With Neoadjuvant Long-Course Chemoradiotherapy: Results of a Matched Pair Analysis.
Markovina S; Youssef F; Roy A; Aggarwal S; Khwaja S; DeWees T; Tan B; Hunt S; Myerson RJ; Chang DT; Parikh PJ; Olsen JR
Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):417-426. PubMed ID: 28871992
[TBL] [Abstract][Full Text] [Related]
32. Efficacy endpoints of radiation therapy group protocol 0247: a randomized, phase 2 study of neoadjuvant radiation therapy plus concurrent capecitabine and irinotecan or capecitabine and oxaliplatin for patients with locally advanced rectal cancer.
Wong SJ; Moughan J; Meropol NJ; Anne PR; Kachnic LA; Rashid A; Watson JC; Mitchell EP; Pollock J; Lee RJ; Haddock M; Erickson BA; Willett CG
Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):116-23. PubMed ID: 25446610
[TBL] [Abstract][Full Text] [Related]
33. Sequential short-course radiation therapy and chemotherapy in the neoadjuvant treatment of rectal adenocarcinoma.
Jia AY; Narang A; Safar B; Zaheer A; Murphy A; Azad NS; Gearhart S; Fang S; Efron J; Warczynski T; Hacker-Prietz A; Meyer J
Radiat Oncol; 2019 Aug; 14(1):147. PubMed ID: 31426827
[TBL] [Abstract][Full Text] [Related]
34. A systematic review and meta-analysis of adjuvant chemotherapy after neoadjuvant treatment and surgery for rectal cancer.
Petrelli F; Coinu A; Lonati V; Barni S
Int J Colorectal Dis; 2015 Apr; 30(4):447-57. PubMed ID: 25433820
[TBL] [Abstract][Full Text] [Related]
35. A Systematic Review and Bayesian Network Meta-Analysis: Short-Term and Long-Term Outcomes of Three Surgery Procedures Following Neoadjuvant Chemoradiotherapy for Rectal Cancer.
Wang L; Zhang Z; Gong L; Zhan Y; Li M; Li S; Xiao Y
J Laparoendosc Adv Surg Tech A; 2019 May; 29(5):663-670. PubMed ID: 30648922
[No Abstract] [Full Text] [Related]
36. Addition of platinum derivatives to neoadjuvant single-agent fluoropyrimidine chemoradiotherapy in patients with stage II/III rectal cancer: protocol for a systematic review and meta-analysis (PROSPERO CRD42017073064).
Hüttner FJ; Probst P; Kalkum E; Hackbusch M; Jensen K; Ulrich A; Büchler MW; Diener MK
Syst Rev; 2018 Jan; 7(1):11. PubMed ID: 29357929
[TBL] [Abstract][Full Text] [Related]
37. The optimal neoadjuvant chemotherapy regimen for locally advanced gastric and gastroesophageal junction adenocarcinoma: a systematic review and Bayesian network meta-analysis.
Wang T; Li C; Li X; Zhai J; Wang S; Shen L
Eur J Med Res; 2022 Nov; 27(1):239. PubMed ID: 36352476
[TBL] [Abstract][Full Text] [Related]
38. Non-operative management after chemoradiotherapy plus consolidation or sandwich (induction with bevacizumab and consolidation) chemotherapy in patients with locally advanced rectal cancer: a multicentre, randomised phase II trial (NOMINATE trial).
Akiyoshi T; Shinozaki E; Taguchi S; Chino A; Hiratsuka M; Tominaga T; Nonaka T; Toda S; Matoba S; Matsui S; Okabayashi K; Mukai T; Hiyoshi Y; Yamaguchi T; Nagasaki T; Yamaguchi K; Ueno M; Kuroyanagi H; Fukunaga Y; Ishizuka N; Konishi T;
BMJ Open; 2022 Mar; 12(3):e055140. PubMed ID: 35304396
[TBL] [Abstract][Full Text] [Related]
39. Comparison of different treatments for HPV+ oropharyngeal carcinoma: a network meta-analysis.
Petrelli F; Nardone M; Trevisan F; Carioli D; Falasca V; De Stefani A; Capriotti V; Gurizzan C; Lorini L; Berruti A; Luciani A; Bossi P
Eur Arch Otorhinolaryngol; 2023 Mar; 280(3):963-971. PubMed ID: 36261656
[TBL] [Abstract][Full Text] [Related]
40. The Effectiveness and Safety of Open Versus laparoscopic Surgery for Rectal Cancer after Preoperative Chemo-radiotherapy: A Meta-Analysis.
Zhang JJ; Guo BL; Zheng QX; Chen ZY
Comb Chem High Throughput Screen; 2019; 22(3):153-159. PubMed ID: 30987563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
